Text Size
12 studies found for:    "Ancylostomiasis"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Completed Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection
Condition: Hookworm Infection
Interventions: Biological: Na-ASP-2/Alhydrogel Hookworm Vaccine;   Biological: Saline placebo
2 Active, not recruiting Prevalence of Hookworm Infection and Community Preparedness for Hookworm Vaccine Trials in Endemic Areas of Brazil
Condition: Hookworm Infection
Intervention: Biological: Na-ASP-2 Skin Test Reagent
3 Active, not recruiting Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma
Conditions: Malaria, Falciparum;   Hookworm Infections;   Schistosoma Haematobium
Intervention: Dietary Supplement: Fe-57 orally, Fe-58 intravenously
4 Completed Randomised Placebo Controlled Study of Effects of Therapeutic Hookworm Infection in Asthma
Condition: Asthma
Intervention: Procedure: Infection with hookworm larvae
5 Recruiting Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults
Conditions: Hookworm Infection;   Hookworm Disease
Interventions: Biological: 10 μg Na-GST-1/Alhydrogel;   Biological: 30 μg Na-GST-1/Alhydrogel;   Biological: 100 μg Na-GST-1/Alhydrogel;   Biological: 10 μg Na-GST-1/ Alhydrogel/GLA-AF;   Biological: 30 μg Na-GST-1/Alhydrogel/GLA-AF;   Biological: 100 μg Na-GST-1/Alhydrogel/GLA-AF;   Biological: Butang® hepatitis B vaccine
6 Not yet recruiting Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults
Conditions: Hookworm Infection;   Hookworm Disease
Interventions: Biological: Na-APR-1 (M74)/Alhydrogel®;   Biological: Gluco-Pyranosylphospho-Lipid A Aqueous Formulation
7 Completed Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
Conditions: Ascariasis;   Trichuriasis;   Hookworm Infection;   Strongyloidiasis;   Pediculosis
Intervention: Drug: albendazole vs. combined albendazole/ivermectin treatment
8 Terminated Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults
Condition: Hookworm Infection
Intervention: Biological: Na-ASP-2 Hookworm Vaccine
9 Completed
Has Results 		Development of a Skin Test for the Na-ASP-2 Hookworm Antigen
Conditions: Hookworm Infection;   Allergy
Intervention: Biological: Na-ASP-2 Skin Test Reagent
10 Recruiting Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant
Conditions: Hookworm Infection;   Hookworm Disease
Interventions: Biological: 10 μg Na-GST-1/Alhydrogel;   Biological: 30 μg Na-GST-1/Alhydrogel;   Biological: 100 μg Na-GST-1/Alhydrogel;   Biological: 10 μg Na-GST-1/Alhydrogel with 1 μg GLA-AF;   Biological: 30 μg Na-GST-1/Alhydrogel with 1 μg GLA-AF;   Biological: 100 μg Na-GST-1/Alhydrogel with 1 μg GLA-AF;   Biological: 10 μg Na-GST-1/Alhydrogel with 5 μg GLA-AF;   Biological: 30 μg Na-GST-1/Alhydrogel with 5 μg GLA-AF;   Biological: 100 μg Na-GST-1/Alhydrogel with 5 μg GLA-AF
11 Completed Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
Conditions: Rhinitis, Allergic, Perennial;   Hayfever;   Allergy
Intervention: Procedure: Infection with hookworm larvae
12 Not yet recruiting Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children
Conditions: Intestinal Helminthiasis;   Ascariasis;   Hookworm;   Malaria
Interventions: Drug: Albendazole;   Drug: Placebo (for Albendazole)
To Top

† Indicates status has not been verified in more than two years